Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Verde Science
AddedFeb 20, 2024
UpdatedJun 18, 2026
Verde Science

Verde Science

Inactive

Verde Science, Inc.: A medical marijuana brand dedicated to innovative research and patient care.

HQ
Dallas, TX, US
Founded
2007
Overview
Compare
Fundraising
Employees
Website

Verde Science, Inc. was founded with the core mission of advancing the medical marijuana industry through innovative research and development. The company is dedicated to creating highly effective formulations for treating chronic medical disorders. Their product line includes a branded array of medical marijuana products, developed with a focus on bioprocess technology, nanotechnology, molecular virology, immunology, pharmacology, and medical device design. Verde Science aims to provide patients with cutting-edge medicinal solutions while supporting ongoing research.

Notable figures associated with Verde Science include a high-level Research and Development Team comprising experts in various scientific fields. The company has achieved significant milestones in isolating new drugs and developing advanced delivery systems for medical treatments. Verde Science's impact lies in its commitment to pioneering research and its contribution to the medical marijuana sector, offering innovative solutions for chronic medical conditions.

Verde Science - Quick Facts

When was Verde Science founded?

Verde Science was founded in 2007.

Where is Verde Science's headquarters located?

Verde Science's headquarters is located in Dallas, TX, US.

When was Verde Science's last funding round?

Verde Science's most recent funding round was for $300k (USD) in May 2014.

How much has Verde Science raised to-date?

As of May 28, 2014, Verde Science has raised a total of $300k (USD).

Verde Science - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Consumers
  • Enterprise
Main Product
  • Medical Marijuana
Tags
  • Biotech
  • Healthtech
  • Research
NAICS
  • 459900Other Miscellaneous Retailers
  • 459990All Other Miscellaneous Retailers
  • 459991Tobacco, Electronic Cigarette, and Other Smoking Supplies Retailers
  • 450000Retail Trade
  • 459000Sporting Goods, Hobby, Musical Instrument, Book, and Miscellaneous Retailers
SIC
  • 1000Metal Mining
Show 5 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 2000Food And Kindred Products
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified